Immunoprecipitation experiments demonstrated the presence of a SMAD2/3/NF-κB complex in lysates of NB cells cultured in the presence of TME cells or treated with rTGF-β1 that was suppressed in the presence of Galunisertib (Fig.  4e). Here, SMAD2 is linked to neuroblastoma.